Table 14.

Recommendations for the nonpharmacological treatment of dyslipidemia in cardiovascular prevention

Indication	Class	Level of evidence
• Control LDL-C	I	A
• Meet the recommended LDL-C level (primary goal)	I	A
• No goals proposed for HDL-C	I	A
• Reduce the intake of saturated fatty acids and trans fatty acids, and consume phytosterols (2-3 g/day) and soluble fibers	I	A
• Increase physical activity	I	A
• Reduce body weight and increase the ingestion of soy proteins; replace saturated fatty acids with mono- and polyunsaturated fatty acids	I	B
• Meet the recommended non-HDL-cholesterol level (secondary goal)	II	A
• Use proper therapy when triglyceride levels > 500 mg/dL to reduce the risk of pancreatitis, and use individualized therapy when triglyceride levels are between 150 and 499 mg/dL	II	A
• No goals proposed for apolipoproteins or lipoprotein(a)	II	A